Please wait while the formulary information is being retrieved.
ENDUR-AMIDE (NIACINAMIDE)
- Niacin deficiency
- Pellagra
ER 500 mg tablet,extended release
- Dosage information is not available
ER 750 mg tablet,extended release
- Dosage information is not available
500 mg tablet,extended release
- Dosage information is not available
750 mg tablet,extended release
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- Arterial hemorrhage
- Peptic ulcer
Contraindicated
- Disease of liver
- Increased risk of bleeding due to coagulation disorder
- Rhabdomyolysis
- Unstable angina pectoris
Severe
Moderate
- Diabetes mellitus
- Gout
- Hypotension
ENDUR-AMIDE (NIACINAMIDE)
- Niacin deficiency
- Pellagra
- None
- Flatulence
- Flushing
- Heartburn
- Stinging of skin
More Frequent
Severe
Less Severe
- None
- Diarrhea
- Dizziness
- Dry skin
- Exacerbation of peptic ulcer
- Hyperglycemia
- Hyperuricemia
- Hypotension
- Nausea
- Pruritus of skin
- Skin rash
- Tachycardia
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
Less Severe
- Abdominal distension
- Blurred vision
- Cardiac arrhythmia
- Headache disorder
- Skin pigmentation enhancement
- Syncope
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Niacin deficiency | |
| E52 | Niacin deficiency [pellagra] |
| Pellagra | |
| E52 | Niacin deficiency [pellagra] |
| 0-9 | A-Z |
|---|---|
| E52 | Niacin deficiency [pellagra] |
| E52 | Niacin deficiency [pellagra] |
Formulary Reference Tool